"iDoctor – Medical Blog"

HOUSTON (MedPage Today) — Studies examining a possible cancer link to insulin glargine (Lantus) produced mixed conclusions that drew quick, reassuring messages from diabetes authorities.

This entry was posted on Tuesday, June 30th, 2009 at 3:15 am and is filed under Health news. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.